NEXGEL, Inc. (NXGL) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Instruments & Supplies 산업에서 운영. 본사 소재지는 Langhorne, PA, 미국. 현재 CEO는 Adam R. Levy.
NXGL 을(를) 보유 IPO 날짜 2021-12-22, 19 명의 정규직 직원, 에 상장 NASDAQ Capital Marke, 시가총액 $6.34M.
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
